Prevalence and Outcomes of Hepatitis B Coinfection and Associated Liver Disease Among Antiretroviral Therapy-Naive Individuals in a Rural Tanzanian Human Immunodeficiency Virus Cohort.
about
Hepatitis B testing and treatment in HIV patients in The Gambia-Compliance with international guidelines and clinical outcomes.Prevention of mother-to-child transmission of HIV Option B+ cascade in rural Tanzania: The One Stop Clinic modelLiver Fibrosis and Hepatitis B Coinfection among ART Naïve HIV-Infected Patients at a Tertiary Level Hospital in Northwestern Tanzania: A Cross-Sectional StudyHIV-hepatitis B virus co-infection: epidemiology, pathogenesis, and treatment.A decade of HIV care in rural Tanzania: Trends in clinical outcomes and impact of clinic optimisation in an open, prospective cohort.HIV/HBV co-infection is a significant risk factor for liver fibrosis in Tanzanian HIV-infected adults.HBV, HCV, and HBV/HCV co-infection among HIV-positive patients in Hunan province, China: Regimen selection, hepatotoxicity, and antiretroviral therapy outcome.Hepatitis B Virus Infection in Tanzania: Current Status and Challenges.
P2860
Q33797424-D4484CBA-06B5-49D6-90D7-0AF8464E318DQ33898494-EA39A9DA-AD72-4D04-95D1-DF052EA8F3A7Q38615081-AF87E4FC-46E5-4B4B-81E3-451115A5D2D9Q39425755-DECD47C8-D67D-40D5-8C9F-102E096059C6Q39553800-4C69421A-E18E-492C-9EFE-CE0E188763FEQ40145541-AB9D820B-B360-4138-AB59-1385263D20BAQ47593919-389D2908-F44A-4FE3-AB0B-7612EC967DDEQ52318586-FF283592-B894-4A2F-BFD6-8F8E21A8A36F
P2860
Prevalence and Outcomes of Hepatitis B Coinfection and Associated Liver Disease Among Antiretroviral Therapy-Naive Individuals in a Rural Tanzanian Human Immunodeficiency Virus Cohort.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prevalence and Outcomes of Hep ...... Immunodeficiency Virus Cohort.
@en
Prevalence and Outcomes of Hep ...... Immunodeficiency Virus Cohort.
@nl
type
label
Prevalence and Outcomes of Hep ...... Immunodeficiency Virus Cohort.
@en
Prevalence and Outcomes of Hep ...... Immunodeficiency Virus Cohort.
@nl
prefLabel
Prevalence and Outcomes of Hep ...... Immunodeficiency Virus Cohort.
@en
Prevalence and Outcomes of Hep ...... Immunodeficiency Virus Cohort.
@nl
P2093
P2860
P50
P356
P1476
Prevalence and Outcomes of Hep ...... Immunodeficiency Virus Cohort.
@en
P2093
Adrià Ramírez-Mena
Alex Ntamatungiro
Annja Winter
Gilles Wandeler
Namvua Kimera
P2860
P304
P356
10.1093/OFID/OFW162
P577
2016-07-29T00:00:00Z